Search Cancer Clinical Trials
Home > Cancer (Oncology) > Research and Clinical Trials > Clinical Trials > Search Cancer Clinical Trials

Research and Clinical Trials

Search Cancer Clinical Trials

Clinical Trials

New Search
Title   A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001
Description   This is a study to determine whether investigational V212 reduces the incidence of herpes zoster (HZ) compared to placebo when administered to recipients of autologous hematopoietic cell transplants (HCT).
Eligibility Criteria   To be eligible for this study, patients must meet several criteria, including but not limited to the following:

* Patient must be 18 Years and older

* Subject has prior history of varicella, antibodies to VZV (documented prior to receipt of blood products), or residence in a country with endemic VZV infection for more than or equal to 30 years or if participant is less than 30 years old, attended primary or secondary school in a country with endemic VZV infection.

* Subject is scheduled to undergo an autologous hematopoietic cell transplant within 60 days of enrollment
Principal Investigator   Ira Braunschweig, MD
Contact Name   Dale Wyville, PA
Phone   (718) 405-8547
Contact Email
Post Date   10/25/2010
Protocol Number   10-09-292/West
Status   Recruting
Current Trial Type   Interventional
Adult Clinical Trial   No
Pediatric Clinical Trial   No